🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

NMTC NMTC

Company Profile ↓
$1.65
-66.59% 1Y
Mkt Cap$13.75M
P/E-3.06
P/B1.94
52W High$6.36
52W Low$1.65
Book Value$0.85
EPS (TTM)$-0.54

Company Overview

NMTC (NMTC) is a publicly traded company listed on with a market capitalization of $13.75M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 145.0% CAGR over the past five years.

Recent Developments

  • Sep 2025 Revenue of $9.10M (+163.5% YoY); net profit $-3.61M.
  • Trailing 12 Months Year-on-year growth — revenue +163.5%.
  • 5-Year Trend Long-term compounding — revenue CAGR 145.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:145.01%
1 Year:163.47%

Stock Price Performance

1 Year:-66.59%
6 Months:-68.02%
3 Months:-62.75%
1 Month:-45.36%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 0% of range
$1.65 $6.36
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)20.79 · Oversold
Price Performance
1M-45.36%
3M-62.75%
6M-68.02%
1Y-66.59%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 145.0% over 5 years.

CONS

  • Trading 74.1% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).
  • RSI at 21 suggests oversold conditions.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-3.06
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$0.85
Price to Book
1.94
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
145.01%
Profit 5Y
-
Revenue (YoY)
163.47%
Earnings (YoY)
-

Profitability & Returns

ROCE
-49.83%
ROE
-50.98%
ROA
-33.43%
Profit Margin
-39.63%
Op Margin
-46.46%
Gross Margin
56.51%
EPS (Latest Qtr)
$-0.28
EPS (TTM)
$-0.54

Balance Sheet & Liquidity

Debt/Equity
3.77
Quick Ratio
3.47
Current Ratio
4.44
Debt
$266.81K
Total Assets
$7.86M
Current Assets
$7.40M
Working Capital
$7.92M

Ownership

Promoter Holding
26.40%
Chg in Prom Hold
0.00%
FII / Inst Holding
22.64%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$9.10M
EBITDA
$-3.01M
Free Cash Flow
$-2.92M
Operating Cash Flow
$-2.84M
Shares Outstanding
8.33M
Gross Margin
56.51%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Dec 2018Mar 2019Jun 2019Dec 2019Mar 2020Jun 2020Dec 2020Mar 2021Jun 2021Dec 2021Mar 2022Jun 2022Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ----------------------71.47K18.24K40.10K33.75K36.58K32.05K114.58K466.18K629.91K977.65K1.38M825.78K-1.39M1.70M2.74M2.89M1.86M
Cost of Revenue -----------------------------------615.49K781.22K1.21M1.32M871.79K
Gross Profit 252165303139-------------------37.66K-21.12K-21.84K-13.10K-36.22K-6.41K-12.31K31.50K243.67K266.31K390.42K281.87K-771.06K914.84K1.53M1.57M990.26K
Operating Expenses -----------------------------------3.45M2.80M2.90M3.28M3.39M
Operating Income -4.73K-3.90K-16.02K-6.12K-1.83K-18.67K-2.59K-4.39K-14.11K-8.60K-516.06K-888.69K-893.79K-773.78K-1.10M-1.17M-1.08M-1.52M-1.86M-1.81M-1.38M-1.59M-2.14M-2.40M-3.03M-2.81M-3.06M-2.76M-1.78M-3.50M-3.51M-3.39M-2.89M-2.79M--2.68M-1.89M-1.37M-1.71M-2.40M
EBITDA ------------------------------------2.20M-1.42M-1.55M-1.37M-2.32M
Interest Expense -----------------------------------09.32K000
Pretax Income ------------------------------------2.27M-1.50M-1.62M-1.44M-2.38M
Tax Provision -----------------------------------00000
Net Income -5.13K-4.23K-16.02K-6.12K-11.58K-22.14K-10.07K-8.96K-24.70K-12.23K-729.58K-1.29M-944.39K-1.63M-1.36M-1.26M-1.35M-2.21M-1.86M-4.64M-1.35M-7.09M-1.96M-2.39M-2.95M-2.81M-3.06M-2.76M-1.73M-3.52M-3.47M-3.34M-2.86M-2.77M--2.27M-1.50M-1.62M-1.44M-2.38M
Diluted EPS -------------------------0.25-0.18-0.19-0.17-0.11-0.21-0.20-0.14-0.11-0.100.36-0.42-0.18--0.18-0.28
R&D Expense ----------72.04K156.72K-234.93K105.05K225.53K209.17K436.31K422.78K501.82K342.10K447.15K934.16K1.08M901.13K1.06M1.21M1.23M1.56M1.71M1.89M1.48M1.27M1.19M1.17M1.51M1.18M-1.39M1.47M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Revenue 1.17K5.40K9211.25K77300---171.17K1.95M3.45M9.10M
Cost of Revenue ----------241.96K1.50M2.37M3.96M
Gross Profit 1.17K3.26K921--------70.79K456.52K1.08M5.14M
Operating Expenses ----------9.96M12.41M12.97M9.37M
Operating Income ----25.09K-35.91K-30.91K-32.61K-5.81M-4.90M--10.03M-11.96M-11.89M-4.23M
EBITDA -----------9.91M-11.66M-11.84M-3.01M
Interest Expense ----------00228.99K334.06K
Pretax Income -----------10.00M-11.86M-12.32M-3.61M
Tax Provision ----------0000
Net Income -6.04K-27.60K-27.60K-30.55K-36.24K-62.86K-47.77K-6.78M-13.64M--10.00M-11.86M-12.32M-3.61M
Diluted EPS -----------3.78-3.90-2.76-0.54
R&D Expense -------1.53M2.08M3.93M4.93M6.94M5.07M4.98M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Sep 2018Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Total Assets -9.13K13.85K1.12K5252051.84K756.93K249.99K218.72K532.62K4.76M-12.82M8.10M5.37M10.79M
Current Assets -------------12.18M7.31M4.63M10.23M
Cash & Equivalents --------26.47K13.26K260.75K4.04M-8.16M5.32M1.46M6.57M
Inventory -------------704.54K1.73M2.64M2.23M
Receivables -------------33.24K0176.64K1.26M
Total Liabilities -13.45K17.13K18.36K30.82K35.59K83.33K1.02M5.29M4.61M1.77M2.69M-3.22M1.85M4.55M3.71M
Current Liabilities -2.95K4.63K18.36K30.82K35.59K83.33K677.19K3.91M3.80M1.77M2.36M-3.10M1.79M2.21M2.30M
Long Term Debt -----------------
Total Debt -------------202.90K184.40K260.16K266.81K
Total Equity 1.22K-4.32K-3.28K-17.24K-30.29K-35.39K-81.49K-266.22K-5.04M-4.40M-1.24M2.07M-9.60M6.25M822.01K7.07M
Shares Outstanding -------------2.70M3.99M5.14M8.33M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Operating Cash Flow -5.09K-27.43K-13.73K-5.40M-3.43M--7.52M-12.89M-11.01M-2.84M
Investing Cash Flow -00-123.35K-122.43K--3.24M2.65M-120.20K-81.74K
Financing Cash Flow 13.00K32.15K1.00K5.77M7.32M-12.02M7.40M7.27M8.03M
Capital Expenditure ----58.35K-122.43K--275.23K-384.12K-120.20K-81.74K
Free Cash Flow ----5.45M-3.55M--7.79M-13.27M-11.13M-2.92M
Net Change in Cash ------1.26M-2.84M-3.86M5.11M

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Sep 2019Sep 2020Sep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Gross Margin % 100.0%60.4%100.0%--------41.4%23.4%31.3%56.5%
Operating Margin % ----2,009.0%-4,646.1%------5,860.2%-612.3%-344.3%-46.5%
Net Margin % -517.9%-511.4%-2,997.2%-2,446.3%-4,688.7%------5,842.0%-607.4%-356.7%-39.6%
ROE % 139.8%842.4%160.1%100.9%102.4%77.1%17.9%547.9%-660.2%--104.1%-189.8%-1,498.5%-51.0%
ROCE % ---82.8%101.5%37.9%-40.9%469.7%-203.9%--103.2%-189.6%-376.6%-49.8%

Shareholding Pattern

Insiders
26.40%
Institutions
22.64%
Public Float
30.76%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NMTC

Google News hu, 25 Jun 2026

NMTC Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE82MkFmNkhXVkJ3NTJrSGVzNUZMRHVVR0ZBTDRKWUU1WlhjTlJydGEtTlQxanoyMFhUMjR5UnlyaldrLW9mdWExSldxWVFKMkQwdlJXRzlRYnRpY2pfWXhuT0Y4Mk1MZ1QtWGhaVU56eWE0eFZCN2Vrd05n?oc=5" target="_blank">NMT…

Google News ue, 14 Apr 2026

NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVHhPY3NEcEFMWjZWYzFhYkpLcVVwenk3cUZFbGVqN2VoX3VXSHlmVUJJZHJ3a3pLcGVrWUlaZnNkLVI1MjdfTGZ3dTVwc01JNGpnX1h1MTJWYVc3OXZZcXhWU2VtUWxlbzBGa2k0Y1JiS1hrZGkySzY3dmp6X216bHNiSmtUa0dMbkVsUn…

Google News ue, 14 Jul 2026

Brian and Barbara Pratt disclose 12.5% NeuroOne stake (NASDAQ: NMTC) - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPQXY3cGlmSWVkY3BNM296eVhiZ0Q2anBEVm9yaE5yU0ZpdUFia0IxbnY5aHpnSTJHTHd0bGdyWFRuU3JlZ1NOVWVmbDItNnZFU0MyVjZSUkJFbC1WWnZUQXNtLUtzcExHRUQtRnpDOXhyY0w0Q3hZUHdHM1NrWEhRNDhjSVNDb2VEYk53SW…

Google News Fri, 31 Jul 2026

NeuroOne Medical Technologies Corp - TradingKey

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE1rN2hTYk1xbHFNeTBnWGZ2emVRX1U3RzVjSXAyZzVBbkxhNDFfUWowQlE3N0pjXzRDbks5VTZaZmNiVzg1ajNPcm1URXhMSHo3ZjNMclFISVhvdk1JQmFEV0pWeUY?oc=5" target="_blank">NeuroOne Medical Technologies Co…

Google News ue, 07 Apr 2026

Bullish NeuroOne Medical Technologies Insiders Rewarded As Their Investment Rises To US$829.9k - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxNZkhJRWo4VS1DcFcxWXRvdTN4US1zdklfX2xTYVBVeHFvNTUxQ1ktVFFEMFFOQVNSWEkxcUVnc0E1bXh5R0pnMGJlOURpOWtvVzhNcXlYYXZCVDczYks4Wkd0QmIwbXI1cHVsWDhUS1UzM01DR3FYSG1vaTFsWFU4NUlsTC1JWktXcVBsMn…

Google News Fri, 24 Jul 2026

NeuroOne Medical Technologies (NMTC) Gains 2.7% as Shares Test Key Resistance Near $1.99 - Vanna Flow - dars.gov.et

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQODgxQ0l1MlY3ZF80UHUwU0RhdU1SeE51SjZhSU1qa3dZX2hSTDFjX29aejhwWDJZVWhvZS16bnRqcGY2NmxOTGQyeG9Xd1IzWWk2YnRvMWY5RTVHSDFmTlhpdjFjQ2RBamltUG5mYkZzbDVOUTc2MnYxaGZtVWNqN19BamZpUGVhcG1oam…

NMTC — Frequently Asked Questions

What is the current share price of NMTC?

As of 2026-08-05 17:25 PDT, NMTC trades at $1.65 on NASDAQ/NYSE. Its 52-week range is $1.65 to $6.36.

What is the market capitalisation of NMTC?

NMTC has a market capitalisation of $13.75M on NASDAQ/NYSE.

What is the P/E ratio of NMTC?

NMTC trades at a trailing price-to-earnings (P/E) ratio of -3.06. Its price-to-book (P/B) ratio is 1.94.

What is the return on equity (ROE) of NMTC?

NMTC has a return on equity (ROE) of -50.98%. Its return on capital employed (ROCE) is -49.83%.

Is NMTC a good stock to buy?

This page provides a data-driven analysis of NMTC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space